qXR-CTR vs ClearRead CT

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Qure.ai
VS
by Riverain Technologies

AI Verdict

Tool A, qXR-CTR, specializes in automating cardiothoracic ratio measurement from chest X-ray images to assess heart size and potential heart failure risk. Tool B, ClearRead CT, focuses on enhancing pulmonary nodule detection and coronary artery calcification analysis in CT scans. While both operate within cardiothoracic imaging, their distinct imaging modalities and specific clinical applications make them adjacent rather than direct competitors.

Choose qXR-CTR if…

Choose qXR-CTR if your primary need is an automated, rapid assessment of heart size and potential heart failure risk directly from standard chest X-ray images. This tool is ideal for initial cardiac screening or situations requiring quick, AI-powered analysis of cardiothoracic ratio without the need for more advanced imaging modalities.

View qXR-CTR →

Choose ClearRead CT if…

Choose ClearRead CT if your focus is on enhancing the detection, characterization, and tracking of pulmonary nodules, or on performing coronary artery calcification scoring from CT scans. This AI suite is best suited for detailed cardiothoracic health assessments that require high diagnostic accuracy, reduced reading times, and comprehensive analysis of CT data for both lung and cardiovascular conditions.

View ClearRead CT →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature qXR-CTR ClearRead CT
Pricing Unknown Contact for pricing
Deployment Can be deployed on cloud or on-premise. The Qure.ai app receives DICOM studies via DICOM network protocol from medical systems (PACS/Modality) or can import DICOM from the local system. The received DICOM study is processed in Qure's cloud server, and AI-processed reports are displayed on the app. On-premise (stand-alone server, virtual machine) and Cloud
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Unknown

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature qXR-CTR ClearRead CT
Name qXR-CTR ClearRead CT
Company Qure.ai Technologies RIVERAIN TECHNOLOGIES
Primary Function AI-powered software that automates the measurement of the cardiothoracic ratio (CTR) from chest X-ray images, aiding in the assessment of heart size and potential heart failure risk. FDA-cleared AI suite for cardiothoracic health, enhancing pulmonary nodule detection and coronary artery calcification analysis in CT scans. Improves diagnostic accuracy, reduces reading times, and streamlines radiology workflows.
Key AI Focus Automated Cardiothoracic Ratio (CTR) assessment from chest X-ray images. Pulmonary nodule detection (solid, part-solid, ground glass), vessel suppression, nodule characterization and measurement, automated nodule tracking, and Coronary Artery Calcification (CAC) scoring.
Specialties Cardiology, Radiology Cardiology, Pulmonology, Radiology

Videos

Demos, reviews, and walkthroughs featuring qXR-CTR and ClearRead CT.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

qXR-CTR is designed for automated cardiothoracic ratio assessment from chest X-ray images. ClearRead CT is an AI suite specifically for CT scans, enhancing pulmonary nodule detection and coronary artery calcification analysis.
qXR-CTR automates the measurement of the cardiothoracic ratio to aid in assessing heart size and potential heart failure risk. ClearRead CT offers pulmonary nodule detection, characterization, measurement, automated tracking, and coronary artery calcification scoring from ungated, non-contrast CTs.
ClearRead CT is stated to reduce reading times by up to 36% and improve detection accuracy with a 29% reduction in missed actionable nodules. qXR-CTR aids in the assessment of heart size and potential heart failure risk, but specific efficiency or accuracy metrics are not detailed in its description.
AI Tool Finder
AI-powered search. Results may not be comprehensive.